Literature DB >> 2041095

Mutational analysis of hepatitis B surface antigen particle assembly and secretion.

V Bruss1, D Ganem.   

Abstract

Cells infected with hepatitis B virus produce both virions and 20-nm subviral (surface antigen or HBsAg) particles; the latter are composed of viral envelope proteins and host-derived lipid. Although hepatitis B virus encodes three envelope proteins (L, M, and S), all of the information required to produce an HBsAg particle resides within the S protein. This polypeptide spans the bilayer at least twice and contains three hydrophobic regions, two of which are known to harbor topogenic signal sequences that direct this transmembrane orientation. We have examined the effects of mutations in these and other regions of the S protein on particle assembly and export. Lesions in the N terminal signal sequence (signal I) can still insert into the endoplasmic reticulum bilayer but do not participate in any of the subsequent steps in assembly. Deletion of the major internal signal (signal II) completely destabilizes the chain. Deletion of the C-terminal hydrophobic domain results in a stable, glycosylated, but nonsecreted chain. However, when coexpressed with wild-type S protein this mutant polypeptide can be incorporated into particles and secreted, indicating that the chain is still competent for some of the distal steps in particle assembly. The correct transmembrane disposition of the N terminus of the molecule is important for particle formation: addition of a heterologous (globin) domain to this region impairs secretion, but the defect can be corrected by provision of an N-terminal signal sequence that restores the proper topology of this region. The resulting chimeric chain is assembled into subviral particles that are secreted with normal efficiency.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041095      PMCID: PMC241412     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Electron microscopy and immunoelectronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes.

Authors:  M A Gerber; S Hadziyannis; C Vissoulis; F Schaffner; F Paronetto; H Popper
Journal:  Am J Pathol       Date:  1974-06       Impact factor: 4.307

2.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

4.  Direct expression of hepatitis B surface antigen in monkey cells from an SV40 vector.

Authors:  C C Liu; D Yansura; A D Levinson
Journal:  DNA       Date:  1982

5.  Isolation and characterization of the major protein and glycoprotein of hepatitis B surface antigen.

Authors:  D L Peterson
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

6.  Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins.

Authors:  F Gavilanes; J M Gonzalez-Ros; D L Peterson
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

7.  A frameshift mutation in the pre-S region of the human hepatitis B virus genome allows production of surface antigen particles but eliminates binding to polymerized albumin.

Authors:  D H Persing; H E Varmus; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Intracellular transport and secretion of hepatitis B surface antigen in mammalian cells.

Authors:  E J Patzer; G R Nakamura; A Yaffe
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

9.  Synthesis of hepatitis B surface antigen in mammalian cells: expression of the entire gene and the coding region.

Authors:  O Laub; L B Rall; M Truett; Y Shaul; D N Standring; P Valenzuela; W J Rutter
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

10.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

View more
  41 in total

1.  Assembly of the coronavirus envelope: homotypic interactions between the M proteins.

Authors:  C A de Haan; H Vennema; P J Rottier
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  A novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis.

Authors:  Xu Yang; Xiao-Peng Tang; Jian-Hua Lei; Hong-Yu Luo; Yong-Hong Zhang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

3.  Deletions in the hepatitis B virus small envelope protein: effect on assembly and secretion of surface antigen particles.

Authors:  R Prange; R Nagel; R E Streeck
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses.

Authors:  Andrés Báez-Astúa; Elsa Herráez-Hernández; Natalio Garbi; Hilda A Pasolli; Victoria Juárez; Harald Zur Hausen; Angel Cid-Arregui
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 5.  Hepatitis B virus morphogenesis.

Authors:  Volker Bruss
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

6.  Expression of large hepatitis B envelope protein mutants using a new expression vector.

Authors:  E Korec; W H Gerlich
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

7.  Use of a prenylation inhibitor as a novel antiviral agent.

Authors:  J S Glenn; J C Marsters; H B Greenberg
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

Review 8.  Quantification of HBsAg: basic virology for clinical practice.

Authors:  Jung Min Lee; Sang Hoon Ahn
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

9.  Functions of the internal pre-S domain of the large surface protein in hepatitis B virus particle morphogenesis.

Authors:  V Bruss; K Vieluf
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Domains of the Hepatitis B Virus Small Surface Protein S Mediating Oligomerization.

Authors:  Sascha Suffner; Nadine Gerstenberg; Maria Patra; Paula Ruibal; Ahmed Orabi; Michael Schindler; Volker Bruss
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.